Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ExPrimary
AddedFeb 17, 2024
UpdatedJun 18, 2026
ExPrimary

ExPrimary

Pre-Seed

ExPrimary, a biotech firm, innovates medical devices for cell analysis, advancing personalized healthcare since 2013.

HQ
Rockville, MD, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

ExPrimary, founded in 2013 and headquartered in Rockville, Maryland, is a biotechnology company focused on developing innovative medical devices for cell analysis. The company's core mission is to enhance access to bioanalytical tools within research and diagnostic markets, particularly to support the growing needs of personalized healthcare. ExPrimary's products are designed to count and store cells efficiently, leveraging advanced technologies to provide high-performance instrumentation at a lower cost compared to existing solutions.

Notable figures affiliated with ExPrimary include experienced professionals from the biotech industry who drive the company's innovative efforts. The company has garnered attention for its state-of-the-art assay content and cost-effective bioanalysis instruments. ExPrimary's impact lies in its ability to democratize access to essential bioanalytical tools, thereby supporting advancements in both research and personalized medicine.

ExPrimary - Similar Companies

Exogenesis logo

Exogenesis

Exotech Bio logo

Exotech Bio

First Choice Bio logo

First Choice Bio

firstchoicebio.com

EarlyCell logo

EarlyCell

Sampling Human logo

Sampling Human

samplinghuman.com

Carmolex logo

Carmolex

ExpressCells logo

ExpressCells

EndoCellutions logo

EndoCellutions

endocellutions.com

Exum Instruments logo

Exum Instruments

Deepcell logo

Deepcell

Evincis Bio logo

Evincis Bio

Excelent logo

Excelent

Exactus logo

Exactus

Celldom logo

Celldom

celldom.com

BiomedInnovations logo

BiomedInnovations

ExPrimary - Quick Facts

Who are ExPrimary's competitors?

Companies similar to ExPrimary include Exogenesis, Exotech Bio, First Choice Bio and EarlyCell.

When was ExPrimary founded?

ExPrimary was founded in 2013.

Where is ExPrimary's headquarters located?

ExPrimary's headquarters is located in Rockville, MD, US.

When was ExPrimary's last funding round?

ExPrimary's most recent funding round was for $100k (USD) in November 2018.

How much has ExPrimary raised to-date?

As of Nov 8, 2018, ExPrimary has raised a total of $100k (USD).

How many employees does ExPrimary have?

ExPrimary has 6 employees as of Feb 5, 2024.

ExPrimary - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthtech
  • Research
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 23 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325413In-Vitro Diagnostic Substance Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 5040Professional And Commercial Equipment And Supplies
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8731Commercial Physical and Biological Research